Local, national & international business news and events.
Billionaire Mike Bloomberg is helping Florida felons pay their debts so they can vote in the presidential election. — ABC News: Top Stories
Frost & Sullivan Names Vonage Asia-Pacific Communications Platform as a Service (CPaaS) Provider of the Year for Second Consecutive Year, HOLMDEL, N.J.–(BUSINESS WIRE)–For the second year in a row, Frost & Sullivan has named Vonage (Nasdaq: VG), a global leader in cloud
Pathline Labs Doubles Testing Capacity for COVID-19, Adds Major Clients Throughout U.S., Testing through Pathline Labs is now available nationwide RAMSEY, N.J.–(BUSINESS WIRE)–Pathline Labs, a leading provider of sub-specialized anatomic pathology, has expanded its COVID-19 testing capabilities across the country while maintaining
LYNPARZA is the Only PARP Inhibitor to Demonstrate Improved Overall Survival in Metastatic Castration-Resistant Prostate Cancer KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced final results from the Phase 3 PROfound
Researchers Share New Data for Vibostolimab (MK-7684), Merck’s Anti-TIGIT Therapy, as Monotherapy and in Combination With KEYTRUDA® (pembrolizumab); First-Time Results for First-in-Class MK-4830 (Anti-ILT4 Therapy); and Late-Breaking Data for MK-6482 (HIF-2α Inhibitor) Merck to Initiate Phase 3 Study of Vibostolimab in Non-Small
The news media landscape has been evolving, where independent bloggers and freelancers are an essential part of the news ecosystem, which supports our democracy. Nevertheless, due to the new digital era and the independent roles that have been established, some bloggers and
Opdivo in combination with CABOMETYX showed superior overall survival and doubled median progression-free survival and objective response rate with a favorable safety profile vs. sunitinib Efficacy benefits were observed across key patient subgroups, including all International Metastatic Renal Cell Carcinoma Database Consortium
Long-Term Findings From EORTC1325/KEYNOTE-054 Show Adjuvant KEYTRUDA Demonstrated a Sustained Recurrence-Free Survival Benefit Versus Placebo Across Stage IIIA (>1 mm Lymph Node Metastasis), IIIB and IIIC Melanoma Merck Is Advancing a Broad Clinical Program Evaluating KEYTRUDA for the Early Treatment of Cancer
Company demonstrates outstanding commitment to delivering high quality drinking water to customers CAMDEN, N.J.–(BUSINESS WIRE)–New Jersey American Water’s Delaware River Regional Water Treatment Plant and Raritan-Millstone Treatment Plant have received the Partnership for Safe Water’s Phase III Directors Award for 20 years